1 Billion people worldwide have soil-transmitted helminths (STHs)​. Integrating geo-statistical methods transmission models to improve monitoring of control programmes. ​@maxeyre3 & @Cbulstra insights for more efficient preventive strategies #BeatNTDsbit.ly/3UuXwuY
ALT Figure 1 from the paper split into five graphs showing the study area and projected impacts of modelling.
🌍 A new study led by @FelixJTeufel, @CBulstra and @mkali_windad offers a new perspective on tackling the global diabetes crisis, inspired by the HIV response! Learn more about how these strategies can be applied to diabetes: thelancet.com/journals/landi…
Join us Wed 13 Dec 13th (9:00AM-1:00PM BRT/7:00AM-11:00AM EST) for the event:
Health Systems and Cancer Initiative-Latin America: Scaling-Up High-Value Health Services for Cancer: Challenges and Opportunities
Register via harvard.az1.qualtrics.com/jf… receive the webinar link.
Today we visited @Ebserh_Gov to learn more about the Brazilian health system and integration of the federal university hospitals. A huge undertaking with significant challenges and opportunities. Thank you to the team for hosting us! #HealthSystems @RifatAtun
Delighted to see our analysis of global cancer research funding published today: Global funding for cancer research between 2016 and 2020: a content analysis of public and philanthropic investments - ScienceDirect sciencedirect.com/science/ar…
Join the 1st International Symposium on Digital Transformation in the SUS online on 2-3 Oct w/ Prof. @RifatAtun and Prof. @Adriano_Massuda!
Register via even3.com.br/simposiointerna….
📣 Join us virtually or in-person TOMORROW AT 12PM for our next seminar presentation by Caroline Bulstra DVM Phd (@CBulstra).
đź’» REGISTER:Â tinyurl.com/Bulstra
Our September issue is now live!
It features trials in NSCLC, serous tubo-ovarian cancer, breast cancer, and glioma, studies on paediatric care in LMICs, reviews on paediatric care, radiotherapy in Latin America, and accelerated approvals, and much more.
thelancet.com/journals/lanon…
On the cover, a study assesses the efficacy and safety of semaglutide 50 mg for the treatment of overweight or obesity in adults without type 2 diabetes.
Find this and more in our latest issue: hubs.li/Q020dDSx0
ALT The Lancet's Aug 26, 2023 issue. Quote: “In adults with overweight or obesity without type 2 diabetes, oral semaglutide 50 mg once per day led to a superior and clinically meaningful decrease in bodyweight compared with placebo.”
2021-22 saw fast change.
The GSF transitioned from the UN to a Swiss Foundation. From expanding our team, to establishing our governance, to testing SURGfund - we have grown quickly.
Thanks to our partners & team: together we have made huge strides.
Read our report below.
To fight the next pandemics we have to fight the current ones. To fight all pandemics we have to fight inequality. To win the fight we have to join together. This coming week comes a new boost as leaders from different fields join together in that struggle. More news to come…
What can we learn from the Silicon Valley approach to medicine? Rohin Francis @MedCrisis looks at the oppportunities and potential pitfalls. Read more: ths.im/3C7B41Z
Released now! Integration of noncommunicable diseases into HIV service packages: technical brief to support country needs into proposal for International funding. Integration of noncommunicable diseases into HIV service packages: technical brief (who.int)